OMB
.report
Search
Outsourcing Facilities: Registration and reporting of drugs under 503B(b)
Human Drug Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
21 USC 353b Sec 503B FFDCA OCT 2022
Outsourcing Facilities: Registration and reporting of drugs under 503B(b)
OMB: 0910-0800
OMB.report
HHS/FDA
OMB 0910-0800
ICR 202210-0910-015
IC 256583
Outsourcing Facilities: Registration and reporting of drugs under 503B(b)
( )
Document [html]
Download:
html
The system is under maintenance. It will be back shortly.
File Type
text/html
File Modified
0000-00-00
File Created
0000-00-00
© 2025 OMB.report |
Privacy Policy